Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis

J Exp Med. 2022 May 2;219(5):e20211681. doi: 10.1084/jem.20211681. Epub 2022 Apr 14.

Abstract

Exonic sequencing identified a family with idiopathic pulmonary fibrosis (IPF) containing a previously unreported heterozygous mutation in POT1 p.(L259S). The family displays short telomeres and genetic anticipation. We found that POT1(L259S) is defective in binding the telomeric overhang, nuclear accumulation, negative regulation of telomerase, and lagging strand maintenance. Patient cells containing the mutation display telomere loss, lagging strand defects, telomere-induced DNA damage, and premature senescence with G1 arrest. Our data suggest POT1(L259S) is a pathogenic driver of IPF and provide insights into gene therapy options.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Idiopathic Pulmonary Fibrosis* / genetics
  • Shelterin Complex
  • Telomerase* / genetics
  • Telomerase* / metabolism
  • Telomere / genetics
  • Telomere / metabolism
  • Telomere-Binding Proteins / genetics

Substances

  • POT1 protein, human
  • Shelterin Complex
  • Telomere-Binding Proteins
  • Telomerase